<![CDATA[
<body> <iframe src="http://www2.blogger.com/navbar.g?targetBlogID=6223270&blogName=biotech+licensing%3A+James+Hatton&publishMode=PUBLISH_MODE_FTP&navbarType=BLUE&layoutType=CLASSIC&homepageUrl=http%3A%2F%2Fwww.jameshatton.com%2Fpublic%2Findex.html&searchRoot=http%3A%2F%2Fblogsearch.google.com%2F" height="30px" width="100%" marginwidth="0" marginheight="0" scrolling="no" id="navbar-iframe" frameborder="0"></iframe> <div id="space-for-ie"></div>
]]>
Links for 2007-02-07
- Altus Lonza Manufacturing and Supply Agreement of November 16, 2006
- Altus Genentech Collaboration and License Agreement of December 19, 2006
- ArQule Chiang Scientific Advisory Board Agreement of January 26, 2007
- CytoDyn CBRI Exclusive License Agreement of January 1, 2007
- SurgiCount A Plus International Exclusive License and Supply Agreement of January 26, 2007
- Praecis Specialty European Pharma Asset Purchase Agreement of January 27, 2007
- Valentis Medarex Asset Purchase Agreement of January 26, 2007
- Brainstorm FIMA Collaboration Agreement of December 26, 2006
- Boston Life Sciences BioAxone Therapeutic License Agreement of December 28, 2006
- Synova Allendale License Agreement, of January 12, 2007
- Valentis Althea Non-Exclusive License Agreement of January 8, 2007
- NuVasive Radius Asset Purchase Agreement of January 23, 2007
- Carrington Mannatech Trademark License and Supply Agreement of January 25, 2007
- Endo Penwest Amended and Restated Strategic Alliance Agreement Amendment of 2007
Royalty rates from 22% to 30% in the US - Grant Life Sciences Intellectual Property Security Agreement of December 27, 2006
- Chemokine Salari Development Termination and Asset Purchase Agreement of December 29, 2006
- Critical Therapeutics Innovative Metabolics License Agreement of January 29, 2007
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home